Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The problem with cephalosporins.

S J Dancer1

  • 1Department of Microbiology, Vale of Leven District General Hospital, Alexandria, Dunbartonshire G83 0UA, UK. stephanie.dancer@vol.scot.nhs.uk

The Journal of Antimicrobial Chemotherapy
|October 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decontamination of environmental surfaces in hospitals to reduce hospital-acquired infections: a systematic review.

Infection prevention in practice·2026
Same author

Carbapenemase genes in the healthcare environment: does it matter?

The Journal of hospital infection·2025
Same author

What is the viable microbiome of the healthcare toilet?

The Journal of hospital infection·2025
Same author

Defending the surface microbiome.

The Journal of hospital infection·2024
Same author

Measurement of SARS-CoV-2 in air and on surfaces in Scottish hospitals.

The Journal of hospital infection·2022
Same author

One size does not fit all: why infection prevention is difficult to randomize or control.

The Journal of hospital infection·2022
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
Same journal

Re-evaluating the 14-day rule: short-course antifungal therapy for uncomplicated candidaemia in a multicentre cohort study.

The Journal of antimicrobial chemotherapy·2026
Same journal

Impact of selective digestive decontamination on the pangenome composition of ESBL-E. coli.

The Journal of antimicrobial chemotherapy·2026
Same journal

Compounds of the γ-carboline family inhibit trans-translation.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Cephalosporin antibiotics, while popular for treating infections, drive the rise of dangerous, multidrug-resistant bacteria. This widespread use threatens future antimicrobial therapies and patient outcomes.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Cephalosporins are widely used broad-spectrum antibiotics in hospitals.
  • Their popularity stems from lower risks and broad efficacy.
  • However, broad-spectrum use promotes antibiotic resistance.

Purpose of the Study:

  • To review the evidence linking cephalosporin use to the emergence of resistant microorganisms.
  • To highlight the long-term implications of cephalosporin-driven resistance on antimicrobial therapy.

Main Methods:

  • Literature review of studies on cephalosporin usage and antimicrobial resistance.
  • Analysis of the selection and propagation mechanisms of resistant pathogens.
  • Discussion of clinical implications and future threats.

Related Experiment Videos

Main Results:

  • Cephalosporin use is a primary driver for the selection of resistant bacteria.
  • Emerging resistant organisms include Clostridium difficile, MRSA, and VRE.
  • These resistant strains pose significant threats to effective infection treatment.

Conclusions:

  • Cephalosporin overuse is a critical factor in the rise of multidrug-resistant organisms.
  • The increasing prevalence of these superinfections jeopardizes future antimicrobial treatment options.
  • Judicious use of cephalosporins is essential to preserve their efficacy.